A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039

Mise à jour : Il y a 4 ans
Référence : NCT00063726

Femme et Homme

Extrait

The purpose of this study is to allow patients to receive VELCADE™ (bortezomib) for Injection who experienced progressive disease(PD) while receiving high-dose dexamethasone from the M34101-039 study.


Critère d'inclusion

  • Multiple myeloma


Liens